Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AZD-3470 by AstraZeneca for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma): Likelihood of Approval
AZD-3470 is under clinical development by AstraZeneca and currently in Phase II for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma). According to...
Data Insights
AZD-3470 by AstraZeneca for Solid Tumor: Likelihood of Approval
AZD-3470 is under clinical development by AstraZeneca and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...